Skip to main content
ImmuneCited

Resveratrol 图表

35 来自同行评审研究的图表

全部 Pelargonium sidoides Glutathione N-Acetylcysteine Astragalus Conjugated Linoleic Acid Curcumin Arginine Astaxanthin Cordyceps Omega-3 Fatty Acids (EPA/DHA) Zinc Quercetin Elderberry Resveratrol Vitamin D Andrographis Iron
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 2. Summary of the mechanistic effects of dietary ω-3 fatty acids and polyphenols on the amyloidogenic pathway. In the context of obesity, IR, and the presence of Aβ, inflammatory pathways are upregulated. ω-3 fatty acids and polyphenols intervene i
Figure 4 Diagram

Summary of the mechanistic effects of dietary ω-3 fatty acids and polyphenols on the amyloidogenic pathway. In the context of obesity, IR, and the presence of Aβ, inflammatory pathways are upregulated.

Mechanisms Linking Obesity, Insulin Resistance, and Alzheimer's Disease: Effects of Polyphenols and …

Figure 1
Figure 1 Diagram

Conceptual diagram summarizing the relationship between modulating Ferroptosis in Aging: The Therapeutic Potential of Natural Products and the biological processes described in this research.

Modulating Ferroptosis in Aging: The Therapeutic Potential of Natural Products.

Figure 2
Figure 2 Diagram

Visual summary of the pathways and interactions relevant to modulating Ferroptosis in Aging: The Therapeutic Potential of Natural Products, as discussed in the context of aging is a multifactorial process driven by accumulating cellular damage.

Modulating Ferroptosis in Aging: The Therapeutic Potential of Natural Products.

Figure 3
Figure 3 Diagram

Schematic representation highlighting the mechanisms underlying modulating Ferroptosis in Aging: The Therapeutic Potential of Natural Products and their potential therapeutic implications.

Modulating Ferroptosis in Aging: The Therapeutic Potential of Natural Products.

Longevity
Figure 16 Chart

Experimental results examining modulating Ferroptosis in Aging: The Therapeutic Potential of Natural Products, with data points illustrating key findings related to aging is a multifactorial process driven by accumulating cellular damage.

Modulating Ferroptosis in Aging: The Therapeutic Potential of Natural Products.

FIGURE 1. Peripheral blood mononuclear cells are stimulated by resveratrol to release anti-inflammatory cytokines, which subsequently prevent chronic inflammation and the growth of cancer cells. M-monocytes and macrophages, L-large lymphocytes, SL-small lym
Figure 1

FIGURE 1. Peripheral blood mononuclear cells are stimulated by resveratrol to release anti-inflammatory cytokines, which subsequently prevent chronic inflammation and the growth of cancer cells. M-monocytes and macrophages, L-large lymphocytes, …

Immunomodulatory and chemopreventive effects of resveratrol on the digestive system cancers.

FIGURE 2. A schematic presentation of some of the mechanisms by which resveratrol may induce cancer cells’ death. The knowledge about the impact of RSV on cuproptosis is limited, as shown by the question mark. Ca cell-cancer cell.
Figure 2

FIGURE 2. A schematic presentation of some of the mechanisms by which resveratrol may induce cancer cells’ death. The knowledge about the impact of RSV on cuproptosis is limited, as …

Immunomodulatory and chemopreventive effects of resveratrol on the digestive system cancers.

Figure 1. Role of lysosomal dysfunction in the progression of cardiovascular disease (CVD). Lysosomal dysfunction, characterized by lysosomal membrane permeabilization and lipid accumulation, leads to the release of cathepsins and reactive oxygen species
Figure 1

Figure 1. Role of lysosomal dysfunction in the progression of cardiovascular disease (CVD). Lysosomal dysfunction, characterized by lysosomal membrane permeabilization and lipid accumulation, leads to the release of cathepsins and …

Lysosomal Stress in Cardiovascular Diseases: Therapeutic Potential of Cardiovascular Drugs and Future …

Figure 2. Therapeutic strategies targeting lysosomal dysfunction in cardiovascular diseases. This schematic illustrates lysosomal dysfunction as a central contributor to CVDs and highlights emerging therapeutic strategies targeting these pathways. Lysosom
Figure 2

Figure 2. Therapeutic strategies targeting lysosomal dysfunction in cardiovascular diseases. This schematic illustrates lysosomal dysfunction as a central contributor to CVDs and highlights emerging therapeutic strategies targeting these pathways. Lysosomal …

Lysosomal Stress in Cardiovascular Diseases: Therapeutic Potential of Cardiovascular Drugs and Future …

Figure 3
Figure 3

Lysosomal Stress in Cardiovascular Diseases: Therapeutic Potential of Cardiovascular Drugs and Future …

Figure 4
Figure 4

Lysosomal Stress in Cardiovascular Diseases: Therapeutic Potential of Cardiovascular Drugs and Future …

第 2 页，共 2 页